Award

Delivery Order #SPE2DR26FV9CV

Delivery Order for Amox-Clav Pharmaceutical Supply to Federal Agency

Buyer

Defense Logistics Agency

Award Amount

$32.48

Ceiling

$32.48

Awarded

March 06, 2026

Period of Performance

Mar 06, 2026 – Mar 09, 2026

Identifier

SPE2DR26FV9CV

NAICS

325411

This award is a delivery order contract issued under an existing Indefinite Delivery Vehicle (IDV) held by AmerisourceBergen Drug Corp., a leading pharmaceutical distribution company. The contract involves the procurement of a specific antibiotic medication, Amoxicillin-Clavulanate potassium suspension, in detailed dosage and packaging. The significance of this award lies in its support of federal healthcare programs by ensuring timely and reliable access to essential medications. The scope covers the delivery of the specified pharmaceutical product to the agency's facility in Conshohocken, Pennsylvania, facilitating continued treatment capabilities. This order is governed under a competitive contract vehicle previously established, reflecting the agency's ongoing commitment to efficient pharmaceutical supply chain management. The contract spans a short, well-defined performance period in early March 2026, reflecting the fulfillment of an immediate or urgent supply need. This delivery order builds on the larger IDV agreement awarded to AmerisourceBergen, which provides a long-term framework for pharmaceutical distribution to federal health initiatives.

Description

4571054789!AMOX-CLAV 600-42.9 MG/5 ML SUS 125ML

View original record